Healthcare Distribution Alliance – Patients Move Us.
Share Print


HDA Announces Robert Mauch and Chad Gielen to Lead Board of Directors

October 5, 2020

ARLINGTON, Va. — The Healthcare Distribution Alliance today announces the election of Robert Mauch, PharmD, PhD, EVP and Group President of AmerisourceBergen Corporation, as Chairman of the HDA Board of Directors. Chad Gielen, President/CEO of Louisiana Wholesale Drug Co. Inc., will serve as Vice Chairman.

Mauch, who served as HDA Vice Chairman for two years, assumes Board leadership from Greg Drew, RPh, President of Value Drug Company. Drew will remain a member of the HDA Executive Committee, which executes HDA’s strategic priorities on behalf of the organization’s Board of Directors.

“While this has been an unprecedented year, I continue to be amazed and humbled by the work, dedication and perseverance of our healthcare distribution industry to serve patients, protect the supply chain and efficiently deliver essential, lifesaving products every day — even in the most challenging of times,” said Bob Mauch. “I am proud to take on this new role with the understanding that partnership, collaboration and the ability of our industry to innovate will ultimately have the greatest impact on both patients and the healthcare ecosystem.”

“I am proud to continue to lend my voice and perspective during a critical time for HDA and the distribution industry, while helping to guide the continued growth of this association,” said Chad Gielen. He has served as a member of the Board of Directors for five years, with two of those years on the Executive Committee.

“I want to welcome Bob and Chad into their new roles, while thanking Greg for his leadership, guidance and service to the pharmaceutical distribution industry during a pivotal time,” said HDA President and CEO Chester “Chip” Davis, Jr. “As we continue the work of communicating the value distributors provide to the overall healthcare ecosystem, I look forward to working in concert with our Executive Committee and Board of Directors to ensure HDA is effectively serving its membership, both today and in the future.”


The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s nonprofit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.


© 2020 Healthcare Distribution Alliance. All rights reserved.
HDA: E | C | C2 | NF | O365